Next-generation Ocumetics Lenses have been successfully manufactured and are ready for the company’s upcoming Group Two first-in-human clinical surgeries in Mexico City. While no efficacy/safety data are provided yet, this is a concrete progress milestone toward initiating clinical procedures, which should modestly improve near-term execution confidence.
Next-generation Ocumetics Lenses have been successfully manufactured and are ready for the company’s upcoming Group Two first-in-human clinical surgeries in Mexico City. While no efficacy/safety data are provided yet, this is a concrete progress milestone toward initiating clinical procedures, which should modestly improve near-term execution confidence.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
